Bio-Rad Laboratories
(BIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Accounts receivable | 2,162,520 | 2,090,030 | 2,063,805 | 2,018,755 | 1,877,483 |
| Accounts payable and accrued liabilities | -1,806,526 | -1,804,028 | -1,664,491 | -1,639,848 | -1,536,935 |
| Other Working Capital | 306,262 | 153,625 | 259,248 | 253,298 | 228,837 |
| Other Operating Activity | -388,944 | -270,491 | -392,082 | -369,470 | -343,476 |
| Operating Cash Flow | $273,312 | $169,136 | $266,480 | $262,735 | $225,909 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -9,631 | 179,117 | -222,619 | -124,704 | -32,650 |
| PPE Investments | -120,774 | -105,444 | -136,544 | -102,654 | -87,263 |
| Net Acquisitions | -44,627 | -72,054 | -39,443 | -158,538 | -89,307 |
| Purchase Sale Intangibles | -15,479 | -700 | -1,780 | -436 | -4,081 |
| Other Investing Activity | -15,479 | -700 | -1,780 | -436 | -7,292 |
| Investing Cash Flow | $-190,511 | $919 | $-400,386 | $-386,332 | $-216,512 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | -253 | N/A | N/A | N/A | 424,633 |
| Debt Repayment | N/A | -300,228 | -620 | -226,835 | -206,706 |
| Common Stock Issued | 15,051 | 11,237 | 10,611 | 14,249 | 12,730 |
| Common Stock Repurchased | N/A | N/A | -101 | N/A | 0 |
| Other Financing Activity | -3,109 | -22,706 | 2,698 | -974 | -1,912 |
| Financing Cash Flow | $11,689 | $-311,697 | $12,588 | $-213,560 | $228,745 |
| Exchange Rate Effect | -12,790 | 9,805 | 10,475 | 4,837 | 18,471 |
| Beginning Cash Position | 331,551 | 463,388 | 574,231 | 906,551 | 649,938 |
| End Cash Position | 413,251 | 331,551 | 463,388 | 574,231 | 906,551 |
| Net Cash Flow | $81,700 | $-131,837 | $-110,843 | $-332,320 | $256,613 |
| Free Cash Flow | |||||
| Operating Cash Flow | 273,312 | 169,136 | 266,480 | 262,735 | 225,909 |
| Capital Expenditure | -120,999 | -106,658 | -142,869 | -102,888 | -88,453 |
| Free Cash Flow | 152,313 | 62,478 | 123,611 | 159,847 | 137,456 |